• RT GLP-3
1 1
HPLC-Verified > 99%

RT GLP-3

RT GLP-3

5mg Lyophilized Peptide • Research Grade
$129.00 USD
$129.00 USD
Sale Sold out
Volume

Third-Party Lab Tested

Download Certificate of Analysis (COA)

TLDR

TL;DR:

A triple GLP-1R/GIPR/GCGR agonist used to investigate incretin and glucagon-receptor co-activation and energy-balance signaling.

Description

Product Description
RT GLP-3 is a unimolecular triple agonist of GLP-1R, GIPR, and GCGR supplied as ≥98% pure lyophilized powder for incretin/glucagon-receptor research.

Key Research Mechanism
Simultaneous engagement of three metabolic GPCRs is used to study energy-expenditure, insulinotropic, and glucagon-receptor signaling in experimental systems.

Primary Research Areas

  • Triple incretin/glucagon pharmacology
  • Energy-homeostasis models
  • GPCR co-agonist design

Intended Use For in vitro and in vivo research only. Not for human or veterinary use. This product is sold strictly for scientific and laboratory investigation. Researchers must follow all institutional and regulatory guidelines. Not evaluated by the FDA.

Shipping & Returns

Orders placed by 3PM will ship same day. All orders placed after 3PM will ship next business day.

Injectables are Non-returnable items
Certain types of items cannot be returned, like perishable goods (such as food, flowers, or plants), custom products (such as special orders or personalized items), and personal care goods (such as beauty products, supplements, and injectables). We also do not accept returns for hazardous materials, flammable liquids, or gases.

Please get in touch if you have questions or concerns about the quality of your specific item and we will work on resolution.

View full details

Certificate of Analysis

Third Party Tested

Molecular Profile

A triple GLP-1R/GIPR/GCGR agonist used to investigate incretin and glucagon-receptor co-activation and energy-balance signaling.

Latest ISO 17025 8× Testing

99.89%

Purity
VariantRT GLP-3
COA ##11581
Labeled50mg
Validation KeyAXISBIOTECH
Tested12/16/25
Full QC Panel - 8× tested ✓
Purity (HPLC) - 99.89% ✓
Net Peptide Content - 50mg ✓
Identity (HPLC) - Retatrutide ✓
Fentanyl Screen - Not Detected ✓
HPLC Conformity mean - >99 ✓
ISO/IEC 17025 Accredited
Storage Requirements

Stability Information

Freeze for storage Refrigerate after reconstitution Protect from light
Lyophilized (powder) −20°C long-term
2–8°C
Reconstituted Recommended condition
Light protection Store away from light

Sealed lyophilized vials are heat-stable; refrigerating or freezing sealed vials is optional. 2–8°C applies to reconstituted solutions.

Peer-Reviewed Literature

Research & References

Research and reference material related to this compound.

01
New England Journal of Medicine · 2023
Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Jastreboff AM, Kaplan LM, Frias JP, Wu Q, Du Y, Gurbuz S, Coskun T, Haupt A, Milicevic Z, Hartman ML
02
The Lancet · 2023
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, phase 2 trial
Rosenstock J, Frias JP, Jastreboff AM, et al.
03
Nature Medicine · 2024
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
Sanyal AJ, Kaplan LM, Frias JP, et al.
04
Cell Metabolism · 2022
LY3437943, a novel triple glucagon, GIP, and GLP-1 receptor agonist for glycemic control and weight loss: from discovery to clinical proof of concept
Coskun T, Urva S, Roell WC, et al.
05
Eli Lilly Press Release · 2025
Lilly's retatrutide delivered weight loss of up to 71.2 lbs in Phase 3 TRIUMPH trial
Eli Lilly and Company
Certificate of Analysis
Download

Precision Synthesis

Developed in collaboration with leading US-based scientific facilities to push the boundaries of biochemical research.

Explore Research Blog

Safety & Regulatory Compliance Warning

These products are intended solely for laboratory research and analytical applications. They have not been evaluated by the U.S. Food and Drug Administration (FDA) and are not approved for therapeutic use, diagnosis, treatment, or prevention of disease. Under no circumstances should these materials be used for human or animal consumption.